Fubotv earnings beat by $0.10, revenue topped estimates
In a challenging market environment, shares of cbdMD, Inc. (NYSE:YCBD) have reached a 52-week low, dipping to $0.2. According to InvestingPro data, the company's financial health score stands at 2.02 (FAIR), with a concerning current ratio of 0.69. The company, known for its broad range of CBD products, has faced significant headwinds over the past year, reflected in a steep 1-year total return of -74.1%. With revenue declining by 18% and an EBITDA of -$1.17M in the last twelve months, investors have shown concern as the stock struggles to find its footing amidst regulatory uncertainties and intense competition within the CBD industry. The current price level marks a critical juncture for YCBD as it navigates through these market pressures. Discover more insights about YCBD's valuation and growth potential in the comprehensive Pro Research Report, available exclusively on InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.